4//SEC Filing
BIOSITE INC 4
Accession 0001238931-07-000004
CIK 0000834306operating
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 8:37 PM ET
Size
14.7 KB
Accession
0001238931-07-000004
Insider Transaction Report
Form 4
BIOSITE INCBSTE
KING GARY
Vice President InternationaOther
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−8,437→ 0 totalExercise: $53.38Exp: 2015-06-17→ Common Stock (8,437 underlying) - Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−9,960→ 0 totalExercise: $25.05Exp: 2012-06-24→ Common Stock (9,960 underlying) - Disposition from Tender
Common Stock
2007-06-29$92.50/sh−414$38,295→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2007-06-29−1,736→ 0 totalExercise: $47.66Exp: 2013-06-18→ Common Stock (1,736 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2007-06-29−2,554→ 0 totalExercise: $44.18Exp: 2014-06-18→ Common Stock (2,554 underlying)
Footnotes (4)
- [F1]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 17,844 shares of Inverness common stock for $13.99 per share.
- [F2]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 3,110 shares of Inverness common stock for $26.61 per share.
- [F3]This option, which provided for daily vesting over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 4,575 shares of Inverness common stock for $24.66 per share.
- [F4]This option, which provided for vesting in sixteen equal quarterly installments over a four-year period commencing on the date of grant, was assumed by Inverness Medical Innovations ("Inverness") pursuant to a merger agreement between the Issuer and Inverness and replaced with an option to purchase 15,115 shares of Inverness common stock for $29.80 per share.
Documents
Issuer
BIOSITE INC
CIK 0000834306
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000834306
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 8:37 PM ET
- Size
- 14.7 KB